High success rates for variety of heroin addiction treatment medications

October 30, 2000

A recent study has shown that levomethadyl acetate (LAAM), buprenorphine, and high doses of methadone (60-100 mg.) were much more effective in treating heroin addiction than low-dose methadone maintenance (20 mg.). LAAM and methadone are available for clinicians to prescribe. Buprenorphine is currently under review by the Food and Drug Administration and is used only in research studies.

"There are nearly one million chronic users of heroin in the United States, and this study is important because it helps to identify the most effective treatments for this devastating addiction," explained Dr. Alan I. Leshner, director of the National Institute on Drug Abuse (NIDA), National Institutes of Health, which provided funding for the research. "This study also furthers our knowledge about the effectiveness of buprenorphine and, ultimately, it may expand the treatment options available to physicians."

A research team led by Dr. Rolley E. Johnson at the Johns Hopkins University School of Medicine conducted the study, published in the November 2 issue of the New England Journal of Medicine. Dr. Johnson's team compared treatment results in 220 volunteers between the ages of 21 and 55, diagnosed as heroin dependent. The volunteers were randomly assigned to one of four treatment groups: LAAM, buprenorphine, high-dose methadone (60 to 100 mg), or low dose methadone (20 mg). There were 55 patients in each group.

For all four treatment groups, reported heroin use decreased by about 90 percent after entering treatment. In addition, all measures--length of time remaining in the study, heroin use during the study, and ratings of drug problem severity--were better for subjects in the LAAM, buprenorphine, and high-dose methadone groups than for those in the low-dose methadone group. All three treatments markedly reduced illicit heroin use. There was little difference in treatment outcomes among the LAAM, buprenorphine, and high-dose methadone treatment groups. LAAM produced the longest duration of continuous abstinence; buprenorphine was similar to LAAM in terms of retention in the study and to high-dose methadone in terms of abstinence.

In the 17-week study, retention rates ranged from 72.7 percent (high-dose methadone group) to 20 percent (low-dose methadone group). LAAM, buprenorphine, and high-dose methadone patients submitted fewer heroin-positive urine samples than did low-dose methadone patients. The percentage of patients with 12 or more consecutive heroin-negative urine specimens differed significantly across the groups. More than one-third of the LAAM patients had 12 or more consecutive negative urine specimens, while only 8 percent of the low-dose methadone patients achieved this number. The percentage of high-dose methadone and buprenorphine patients reaching this mark was only slightly less than the LAAM group.

Patients in the LAAM and buprenorphine groups were given these drugs three times a week, and patients in both methadone groups received daily doses. Dr. Johnson said that not having to administer LAAM or buprenorphine on a daily basis gives these drugs a clinical advantage. "Less-than-daily dosing," he says, "reduces the need for take-home medication, requires fewer clinic visits, and allows a more normal lifestyle."
-end-
The National Institute on Drug Abuse is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports more than 85 percent of the world's research on the health aspects of drug abuse and addiction. The Institute carries out a large variety of programs to ensure the rapid dissemination of research information and its implementation in policy and practice. Fact sheets on the health effects of drugs of abuse and other topics can be ordered free of charge in English and Spanish by calling NIDA Infofax at 1-888-NIH-NIDA (644-6432) or 1-888-TTY-NIDA (889-6432) for the deaf. These fact sheets and further information on NIDA research and other activities can be found on the NIDA home page at http://www.drugabuse.gov.

NIH/National Institute on Drug Abuse

Related Heroin Articles from Brightsurf:

From pills to powder: 1 in 3 high school seniors who misused prescription opioids later used heroin
Nearly one-third of students who reported misusing prescription opioids as high school seniors between 1997 and 2000, but did not have a history of medical use, later used heroin by age 35, according to a University of Michigan study.

Heroin-addicted individuals have unique brain disturbances resembling those of Alzheimer's
Herion-addicted individuals have alterations in the expression a gene called FYN - a gene known to regulate the production of Tau, a protein that is highly elevated and implicated in neurocognitive disorders like Alzheimer's disease.

Large majority of Washington state's heroin users want to reduce use
A new survey of people who inject illicit drugs in the state of Washington yields positive and important findings for policy makers as the world struggles to deal with the COVID-19 pandemic.

Heroin use in US
Survey responses from a nationally representative group of 800,000 US adults were used to examine changes in heroin use, heroin injection and heroin use disorder from 2002 to 2018.

State prescription drug monitoring programs: The rise and fall in heroin fatalities
A new study found a consistent association between the adoption of state Prescription Drug Monitoring programs (PDMP) and death rates from heroin poisoning.

Fingerprint test can distinguish between those who have taken or handled heroin
A state-of-the-art fingerprint detection technology can identify traces of heroin on human skin, even after someone has washed their hands -- and it is also smart enough to tell whether an individual has used the drug or shaken hands with someone who has handled it.

What to call someone who uses heroin?
A first-of-its-kind study by researchers from the Boston University School of Public Health (BUSPH) and the University of Massachusetts Medical School (UMMS), published in the journal Addiction, has found that people entering treatment for heroin use most often called themselves 'addicts,' but preferred that others called them 'people who use drugs.'

Teens abusing painkillers are more likely to later use heroin
A USC study in the July 8, 2019 issue of JAMA Pediatrics shows that teens who use prescription opioids to get high are more likely to start using heroin by high school graduation.

Is nonmedical opioid use by adolescents associated with later risk of heroin use?
This observational study used data from a survey of behavioral health that included students from 10 Los Angeles-area high schools to examine whether nonmedical prescription opioid use was associated with later risk of heroin use in adolescents.

CBD reduces craving and anxiety in people with heroin use disorder
Mount Sinai study highlights the potential of cannabidiol as a treatment option for opioid abuse.

Read More: Heroin News and Heroin Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.